Literature DB >> 25127026

The effects of intravenous vitamin C on point-of-care glucose monitoring.

Zach Sartor1, Jenna Kesey, Sharmila Dissanaike.   

Abstract

Ascorbic acid (vitamin C) decreases systemic inflammation and lowers fluid requirements after thermal injury; therefore it has been adopted in many burn centers as an adjunct to resuscitation. However, recent concerns have been expressed over clinically significant hypoglycemic events caused by vitamin C interference with the point-of-care (POC) glucose measurements. This case series presents a direct comparison of POC and laboratory reference glucose values in the patients receiving vitamin C infusion. Vitamin C was administered at 66 mg/kg/hour in seven patients with burns >30% TBSA. The baseline characteristics and burn characteristics were recorded. POC glucose measurements were made with a commonly used hand-held device, and the laboratory values were obtained using standard spectrophotometric methods. POC and laboratory glucose values drawn within the same hour were compared. Hemoglobin, which is known to cause interference in POC testing, was also recorded. All the patients demonstrated falsely elevated POC glucose values during and/or immediately after the infusion period, with discrepancies ranging from 10 to 200 mg/dl. These findings were irregular, unpredictable and unrelated to hemoglobin levels. The findings suggest an idiosyncratic reaction that cannot be easily corrected at the bedside using mathematical equations. POC glucose monitoring should be avoided during and after vitamin C therapy.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25127026     DOI: 10.1097/BCR.0000000000000142

Source DB:  PubMed          Journal:  J Burn Care Res        ISSN: 1559-047X            Impact factor:   1.845


  14 in total

1.  Impact of High-Dose Intravenous Vitamin C for Treatment of Sepsis on Point-of-Care Blood Glucose Readings.

Authors:  Anna Peyton Howell; Jenna L Parrett; Daniel R Malcom
Journal:  J Diabetes Sci Technol       Date:  2019-11-25

2. 

Authors:  F Ravat; R Le Floch
Journal:  Ann Burns Fire Disasters       Date:  2015-12-31

Review 3.  Vitamin C in sepsis.

Authors:  Sven-Olaf Kuhn; Konrad Meissner; Lena M Mayes; Karsten Bartels
Journal:  Curr Opin Anaesthesiol       Date:  2018-02       Impact factor: 2.706

4.  Any Role of High-Dose Vitamin C for Septic Shock in 2021?

Authors:  Ankita Agarwal; David N Hager; Jonathan E Sevransky
Journal:  Semin Respir Crit Care Med       Date:  2021-09-20       Impact factor: 3.921

5.  Delayed Diagnosis of Severe Hypoglycemia in a Septic Patient With Chronic Renal Failure.

Authors:  Daan Ten Berge; Fokko Manning; Vera Silderhuis; Saskia Deijns; Marie-Jose Pouwels; Hans Krabbe; Albertus Beishuizen
Journal:  Cureus       Date:  2022-08-31

6.  A Retrospective Analysis of Clinical Laboratory Interferences Caused by Frequently Administered Medications in Burn Patients.

Authors:  Zachary Godwin; Kelly Lima; David Greenhalgh; Tina Palmieri; Soman Sen; Nam K Tran
Journal:  J Burn Care Res       Date:  2016 Jan-Feb       Impact factor: 1.845

Review 7.  Burn injury.

Authors:  Marc G Jeschke; Margriet E van Baar; Mashkoor A Choudhry; Kevin K Chung; Nicole S Gibran; Sarvesh Logsetty
Journal:  Nat Rev Dis Primers       Date:  2020-02-13       Impact factor: 52.329

8.  Liposomal-encapsulated Ascorbic Acid: Influence on Vitamin C Bioavailability and Capacity to Protect Against Ischemia-Reperfusion Injury.

Authors:  Janelle L Davis; Hunter L Paris; Joseph W Beals; Scott E Binns; Gregory R Giordano; Rebecca L Scalzo; Melani M Schweder; Emek Blair; Christopher Bell
Journal:  Nutr Metab Insights       Date:  2016-06-20

9.  A Case of Factitious Hyperglycemia in a Patient on Intravenous Ascorbic Acid.

Authors:  Eliza Sharma; Christine Resta; Patricia Park
Journal:  Case Rep Endocrinol       Date:  2018-05-14

10.  Pseudohyperglycemia Secondary to High-Dose Intravenous Vitamin C Managed as Diabetic Ketoacidosis: An Endocrinological Catastrophe.

Authors:  Israel B Orija; Syeda Hira Zahid
Journal:  AACE Clin Case Rep       Date:  2020-11-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.